MedPath

Cost-effectiveness of cognitive behaviour therapy of cognitive behaviour therapy for recent onset schizophrenia patients with persistent and recurrent psychosis.

Completed
Conditions
Schizophrenia
Mental and Behavioural Disorders
Registration Number
ISRCTN57292778
Lead Sponsor
niversity Medical Center Groningen (Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
230
Inclusion Criteria

1. Schizophrenia patients in the first five years after onset
2. Age 18-64
3. Treatment resistant or recurrent psychosis

Exclusion Criteria

1. IQ<80
2. Severe addiction
3. No competence of Dutch language
4. 4 or more CBT sessions in the last year

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Days functioning in normal range based on PSYRAYS and SFS: minimal suffering and functional restrictions by delusions and/or hallucinations and SFS normal social functioning.
Secondary Outcome Measures
NameTimeMethod
1. Medication compliance<br>2. Number of relapses<br>3. Psychiatric symptoms<br>4. Quality of life
© Copyright 2025. All Rights Reserved by MedPath